日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting Aurora kinase B regulates cholesterol metabolism and enhances chemoimmunotherapy in cholangiocarcinoma

靶向 Aurora 激酶 B 可调节胆固醇代谢并增强胆管癌的化疗免疫疗法疗效

Liu, Furong; Chen, Wei; Zhang, Ze; Zeng, Weifeng; Hu, Haofan; Ning, Shangwu; Liao, Zhibin; Liu, Yachong; Zhang, Hongwei; Fu, Qinggang; Zhang, Bixiang; Chen, Xiaoping; Zhang, Wanguang; Zhang, Zhanguo

Targeting SPAK suppresses progression and averts an immune exhaustive microenvironment in hepatocellular carcinoma

靶向SPAK可抑制肝细胞癌的进展并避免免疫耗竭的微环境。

Pan, Yonglong; Zeng, Chenglong; He, Yi; Chang, Ruizhi; Wu, Jingjing; Yuan, Chaoyi; Li, Haisen; Su, Chen; Han, Mengzhen; Li, Pengcheng; Li, Xinxin; Zhang, Hongwei; Liu, Furong; Liang, Huifang; Li, Zifu; Wu, Mi; Xia, Limin; Liu, Jianfeng; Chen, Xiaoping; Zhang, Wanguang; Zhang, Bixiang; Ding, Ze-Yang

Development and Internal Multicenter Validation of a Deep Learning Model for Predicting Post-Hepatectomy Liver Failure in Patients with Hepatocellular Carcinoma: A Multicenter Study

开发和内部多中心验证用于预测肝细胞癌患者肝切除术后肝功能衰竭的深度学习模型:一项多中心研究

Chen, Qian; Xia, Feng; Guo, Bin; Liu, Zhicheng; Liu, Xulin; Shu, Chang; Yan, Jing; Qiu, Zhancheng; Zhang, Qiao; Wu, Zhenheng; Huang, Zhiyuan; Chen, Xiaoping; Zhang, Bixiang; Zhu, Peng

Cancer stem cells and niches: challenges in immunotherapy resistance

癌症干细胞和微环境:免疫疗法耐药性的挑战

Pan, Yonglong; Yuan, Chaoyi; Zeng, Chenglong; Sun, Chaoyang; Xia, Limin; Wang, Guihua; Chen, Xiaoping; Zhang, Bixiang; Liu, Jianfeng; Ding, Ze-Yang

Neuroscience of cancer: unraveling the complex interplay between the nervous system, the tumor and the tumor immune microenvironment

癌症神经科学:揭示神经系统、肿瘤和肿瘤免疫微环境之间复杂的相互作用

Huang, Qibo; Hu, Bai; Zhang, Ping; Yuan, Ye; Yue, Shiwei; Chen, Xiaoping; Liang, Junnan; Tang, Zhouping; Zhang, Bixiang

Gut microbiota-mediated gut-liver axis: a breakthrough point for understanding and treating liver cancer

肠道菌群介导的肠-肝轴:理解和治疗肝癌的突破点

Li, Chenyang; Cai, Chujun; Wang, Chendong; Chen, Xiaoping; Zhang, Bixiang; Huang, Zhao

VRK2 targeting potentiates anti-PD-1 immunotherapy in hepatocellular carcinoma through MYC destabilization

VRK2靶向治疗通过MYC去稳定化增强抗PD-1免疫疗法在肝细胞癌中的疗效

Su, Chen; Liao, Zhibin; Mo, Jie; Liu, Furong; Wang, Weijian; Zhang, Haoquan; Zhang, Hongwei; Liu, Yachong; Pan, Yonglong; Zhu, He; Chen, Xiaoping; Zhang, Zhanguo; Zhu, Peng; Zhang, Bixiang

Disrupting CCDC137-mediated LZTS2 and β-TrCP interaction in the nucleus inhibits hepatocellular carcinoma development via β-catenin and AKT

破坏细胞核内CCDC137介导的LZTS2和β-TrCP相互作用可通过β-catenin和AKT抑制肝细胞癌的发生发展。

Xu, Lei; Liu, Qiumeng; Liu, Hailing; Fan, Feimu; Li, Pengcheng; Yue, Shiwei; Mo, Jie; Liu, Zhicheng; Dong, Renshun; Zhang, Xuewu; Dong, Hanhua; Liang, Huifang; Chen, Xiaoping; Zhang, Bixiang; Chen, Lin; Chen, Jin

CKAP4 in hepatocellular carcinoma: competitive RETREG1/FAM134B binding, reticulophagy regulation, and cancer progression.

CKAP4 在肝细胞癌中的作用:竞争性 RETREG1/FAM134B 结合、网状吞噬调控和癌症进展

Mo Jie, Su Chen, Li Pengcheng, Yang Zhenhua, Tao Ran, Liu Qiumeng, Yuan Chaoyi, Xu Lei, Ge Qianyun, Ning Deng, Liang Huifang, Zhu Haidan, Luo Yan, Chen Xiaoping, Chen Jin, Zhang Bixiang

m(6)A-Mediated TMCO3 Promotes Hepatocellular Carcinoma Progression by Facilitating the Membrane Translocation and Activation of AKT

m(6)A介导的TMCO3通过促进AKT的膜转位和激活来促进肝细胞癌的进展。

Li, Xinxin; Han, Mengzhen; Zhu, He; Pan, Yonglong; Su, Chen; Liu, Yachong; Liao, Zhibin; Zhang, Bixiang; Chen, Xiaoping